“…ECFCs, a unique population of EPCs, possess high proliferation, self-renewal and in vivo vasculogenic potential (Melero-Martin et al, 2007;Richardson and Yoder, 2011), which show good promise in application of vessel repair (Lavergne et al, 2011). In this study, we found successive ECFCs transfusion retarded CA wall degeneration upon homing to aneurysmal wall (Fang et al, 2012;Li et al, 2013). Growing evidence suggests that degeneration of vessel wall followed by vascular remodeling and aneurysm enlargement is associated with CA prone to rupture (Aoki et al, 2008a; Kataoka et al, 1999).…”